JM, L., AJ, S., J, C., J, J., G, H., & SC, R. (2026). Targeting CD73 and correcting adenosinergic signaling in critically ill patients. Frontiers in pharmacology, 16, 1601481. https://doi.org/10.3389/fphar.2025.1601481
Chicago Style (17th ed.) CitationJM, Lunderberg, Spicer AJ, Cassavaugh J, Jalkanen J, Haskó G, and Robson SC. "Targeting CD73 and Correcting Adenosinergic Signaling in Critically Ill Patients." Frontiers in Pharmacology 16 (2026): 1601481. https://doi.org/10.3389/fphar.2025.1601481.
MLA (9th ed.) CitationJM, Lunderberg, et al. "Targeting CD73 and Correcting Adenosinergic Signaling in Critically Ill Patients." Frontiers in Pharmacology, vol. 16, 2026, p. 1601481, https://doi.org/10.3389/fphar.2025.1601481.
Warning: These citations may not always be 100% accurate.